🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,063 results for “BRIGHT MINDS BIOSCIENCES INC.” Clear

  1. Emixustat

    BRIGHT MINDS BIOSCIENCES INC.

    Stargardt Disease

    phase 3 small molecule completed

    1 trial

  2. Empowered Relief On-Demand

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    phase 3 other completed

    1 trial

  3. Enhanced care

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Addiction

    phase 3 other completed

    1 trial

  4. Erythromycin

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 3 small molecule completed

    1 trial

  5. Escitalopram

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 3 small molecule completed

    1 trial

  6. Extended Release Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorder

    phase 3 small molecule completed

    1 trial

  7. Extended Release Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 3 small molecule completed

    1 trial

  8. Extended treatment

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 3 small molecule completed

    1 trial

  9. Fluoxetine

    BRIGHT MINDS BIOSCIENCES INC.

    Major Depressive Disorder

    phase 3 small molecule completed

    1 trial

  10. Gabapentin

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Dependence

    phase 3 small molecule completed

    1 trial

  11. Gabapentin 300mg

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol Drinking

    phase 3 small molecule completed

    1 trial

  12. H. pylori vaccine

    BRIGHT MINDS BIOSCIENCES INC.

    H. Pylori Infection

    phase 3 mab completed

    1 trial

  13. HealthWise South Africa curriculum

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    phase 3 other completed

    1 trial

  14. Hypnotic Medication Open-Label Taper

    BRIGHT MINDS BIOSCIENCES INC.

    Hypnotic Dependence Among Those With Insomnia

    phase 3 other active

    1 trial

  15. Internet-based smoking treatment

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 3 other completed

    1 trial

  16. Learning Session

    BRIGHT MINDS BIOSCIENCES INC.

    Addiction

    phase 3 other completed

    1 trial

  17. Live-Attenuated influenza Vaccine(LAIV)

    BRIGHT MINDS BIOSCIENCES INC.

    Influenza

    phase 3 mab completed

    1 trial

  18. Lofexidine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Withdrawal

    phase 3 small molecule completed

    1 trial

  19. Lofexidine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 3 small molecule completed

    3 trials

  20. Lofexidine

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Addiction

    phase 3 small molecule completed

    1 trial

  21. Lofexidine HCl

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    phase 3 small molecule completed

    1 trial

  22. Losartan

    BRIGHT MINDS BIOSCIENCES INC.

    Glomerulonephritis, IGA

    phase 3 small molecule completed

    1 trial

  23. MORE

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use

    phase 3 other active

    1 trial

  24. MORE and MI and NRT

    BRIGHT MINDS BIOSCIENCES INC.

    Polysubstance Abuse

    phase 3 other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources